← Open Payments lookup

AARON CUNNINGHAM: Open Payments

NPI 1508190695 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,175 in 38 payments from 10 companies in 2025. Trend: 2023 $137 · 2024 $64 · 2025 $1,175

Food & beverage: $1,024Education: $151
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$318
Astellas Pharma US Inc5$252
GlaxoSmithKline, LLC.8$142
Verona Pharma, Inc.4$105
Boehringer Ingelheim Pharmaceuticals, Inc.3$80
United Therapeutics Corporation3$76
Takeda Pharmaceuticals U.S.A., Inc.2$68
Genentech USA, Inc.3$55
Regeneron Healthcare Solutions, Inc.2$48
GENZYME CORPORATION1$30

Products named: FASENRA, NUCALA, AIRSUPRA, Ohtuvayre, Cresemba, OFEV, DUPIXENT, Tyvaso.

Industry payments across PA — which companies pay providers there.